For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240126:nRSZ1178Ba&default-theme=true
RNS Number : 1178B Volex PLC 26 January 2024
26 January 2024
Volex plc
("Volex" or the "Company")
Director / PDMR Shareholding
Volex plc (AIM: VLX) announces that on Wednesday 24 January 2024, Nat
Rothschild, Executive Chairman, exercised a nil-cost award over ordinary
shares of 25 pence each in the company ("Ordinary Shares") granted to him
under the Volex plc Long Term Incentive Plan (the 'LTIP Award').
The LTIP Award was granted on 10 September 2019 subject to performance
conditions being met relating to profit and relative total shareholder return
("TSR"). The Company's remuneration committee assessed the performance
conditions and determined that 680,000 awards should be granted pursuant to
the LTIP Award, and consequently, Nat Rothschild has exercised 680,000 LTIP
Awards over Ordinary Shares.
The LTIP Award will be satisfied using existing shares purchased in the market
by the trustee of the Company's employee benefit trust. The Ordinary
Shares acquired on exercise are subject to a holding period expiring 10
September 2025.
Following the exercise of the LTIP Award, Nat Rothschild(1) is interested in
46,539,426 shares Ordinary Shares (save for unvested or unexercised awards),
representing approximately 25.62 per cent. of the Company's issued share
capital.
(1) Including those shares held through NR Holdings Ltd, of which Nat
Rothschild is a beneficiary.
For further information please contact:
Volex plc +44 (0)7971 156 431
Nat Rothschild, Executive Chairman investor.relations@volex.com
Jon Boaden, Chief Financial Officer
Peel Hunt LLP - Nominated Adviser & Joint Broker +44 (0)20 7418 8900
Ed Allsopp
Tom Ballard
Ben Harrington
HSBC Bank plc - Joint Broker +44 (0)20 7991 8888
Simon Alexander
Joe Weaving
Powerscourt - Media Enquiries +44 (0)20 7250 1446
James White
The information below (set out in accordance with the requirements of EU
Market Abuse Regulation) provides further detail:
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Nat Rothschild
2 Reason for the notification
a) Position/status PDMR, Executive Chairman
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Volex PLC
b) LEI 213800HBLQNH5FXXGE63
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 25 pence each
Identification code
b) Nature of the transaction Exercise of award granted under the Volex plc Long Term Incentive Plan to
acquire ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
£nil 680,000
d) Aggregated information
- Aggregated volume
- Price 680,000
£nil
e) Date of the transaction 24 January 2024
f) Place of the transaction Outside a trading venue
About Volex
Volex plc (AIM: VLX) is a global leader in integrated manufacturing for
performance-critical applications and a supplier of power products. We serve a
diverse range of markets and customers, with particular expertise in cable
assemblies, higher-level assemblies, data centre power and connectivity,
electric vehicles, and consumer electricals. We are headquartered in
the UK and operate from 27 manufacturing locations with a global workforce
of over 11,500 people across 24 countries. Our products are sold through our
own locally based sales teams and through authorised distributor partners to
Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing
Services ('EMS') companies worldwide. All of the products and services that we
offer are integral to the increasingly complex digital world in which we live,
providing power and connectivity from the most common household items to the
most complex medical equipment. For more information, please
visit www.volex.com (http://www.volex.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDQLFLZFLBBBK